Your browser doesn't support javascript.
loading
Erratum to: Infusion of donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene for recurrent hematologic malignancies after allogeneic hematopoietic stem cell transplantation.
Hashimoto, Hisayoshi; Kitano, Shigehisa; Ueda, Ryosuke; Ito, Ayumu; Tada, Kohei; Fuji, Shigeo; Kim, Sung-Won; Yamashita, Takuya; Tomura, Daisuke; Nukaya, Ikuei; Mineno, Junichi; Fukuda, Takahiro; Mori, Shinichiro; Takaue, Yoichi; Heike, Yuji.
Afiliação
  • Hashimoto H; Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Kitano S; Division of Experimental Therapeutics, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Ueda R; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Ito A; Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Tada K; Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Fuji S; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Kim SW; Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Yamashita T; Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Tomura D; Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Nukaya I; Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Mineno J; Center for Cell and Gene Therapy, Takara Bio Inc, Seta 3-4-1, Otsu, Shiga, 520-2193, Japan.
  • Fukuda T; Center for Cell and Gene Therapy, Takara Bio Inc, Seta 3-4-1, Otsu, Shiga, 520-2193, Japan.
  • Mori S; Center for Cell and Gene Therapy, Takara Bio Inc, Seta 3-4-1, Otsu, Shiga, 520-2193, Japan.
  • Takaue Y; Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Heike Y; Division of Hematology and Oncology, St. Luke's International Hospital, 9-1 Akashi-cho, Chou-ku, Tokyo, 104-8560, Japan.
Int J Hematol ; 102(4): 506, 2015 Oct.
Article em En | MEDLINE | ID: mdl-26362857
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2015 Tipo de documento: Article